Publication | Closed Access

Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors

Prognostic BiomarkersAdvanced Lung DiseaseLung InflammationMedicineImmune-related PneumonitisProgrammed Death 1ImmunologyTumor ImmunityPrognosisImmune SurveillanceImmune Checkpoint InhibitorOncologyRadiation OncologyRisk FactorsLung CancerCancer ResearchHealth Sciences